Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma
Simon Heidegger, Ambros Beer, Eva Geissinger, Andreas Rosenwald, Christian Peschel, Ingo Ringshausen, Ulrich Keller
Research output: Contribution to journal › Article › peer-review
8Scopus
citations
Fingerprint
Dive into the research topics of 'Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma'. Together they form a unique fingerprint.